Network and Endpoint Security leader Sophos has announced that it is acquiring Invincea from its current shareholders for a cash consideration of $100 million with a $20 million earn-out.
Invincea, a visionary provider of next-generation malware protection has been consistently ranked as among the best performing machine learning, signature-less next-generation endpoint technologies in third-party testing.
Invincea has also been rated highly both for high detection and detection and low false-positive rates. Its endpoint security portfolio is designed to detect and prevent unknown malware and sophisticated attacks via its patented deep learning neural network algorithms. Its flagship product X by Invincea uses deep learning neural networks and behavioral monitoring to detect previously unseen malware and stops attacks before damage occurs.
According to the founder, Chief Executive Officer Anup Ghosh Invincea was founded to address the rapidly growing zero-day security threat from nation states, cyber criminals, and rogue actors. With a focus on the U.S. government, healthcare, and financial services sectors, Invincea has been deployed in some of the most targeted networks in the world.
By adding Invincea to our portfolio, Kris Hagerman, Chief Executive Officer at Sophos says the company is executing on its vision to assemble the most powerful technologies to provide the very best, cutting-edge defenses for our customers. “Invincea is leading the market in machine learning-based threat detection with the combination of superior detection rates and minimal false positives.’’ H said Invincea will strengthen Sophos’ leading next-gen endpoint protection with complementary predictive defenses that will become increasingly important to the future of endpoint protection and allow Sophos to take full advantage of this significant new growth opportunity.
‘’We are proud to welcome the Invincea team to Sophos and look forward to introducing the benefits of this advanced technology to our customers and partners worldwide,” he said.
The Invincea machine learning malware detection and prevention technology will be fully integrated into the Sophos endpoint protection portfolio, further strengthening Sophos’ leadership in this fast-growing market. The availability of Invincea technology through the Sophos Central security management platform will further enhance the Sophos synchronized security portfolio and real-time intelligence sharing.
“We started Invincea with the vision of using non-signature based technologies, including machine learning, in innovative ways to protect organizations against the most advanced forms of cyber-attack,” said Anup Ghosh, founder and chief executive officer at Invincea, adding that X by Invincea represents a new generation in antivirus technology based on deep learning and behavioral monitoring. ‘’Joining forces with Sophos presents the perfect opportunity to take our proven, advanced technology to a global audience and make it part of a comprehensive synchronized security system. Sophos is leading the industry in adopting and bringing to market this disruptive new vision for complete, advanced, and integrated security, and we are delighted to join the team and help make it happen.”
Norm Laudermilch, chief operating officer and head of product development at Invincea added that Invincea set out to disrupt the traditional approach to antivirus, and even now no single technology is enough to fully protect customers. The Invincea endpoint security portfolio including X by Invincea will continue to be supported and sold by Invincea and available via Invincea’s network of registered partners.
Under this acquisition agreement, Sophos will retain the company’s office in Fairfax where it is headquartered. Invincea CEO Anup Ghosh and COO Norm Laudermilch will also join Sophos in key leadership positions. Consummation of the transaction is subject to the satisfaction of various closing conditions. Invincea Labs, a division of Invincea that has been separately managed and operated since 2012, has also been separated prior to the acquisition and is not part of this transaction.